ArticlebioRxiv : the preprint server for biology2024

Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinoma.

Saireudee Chaturantabut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.